Co-Diagnostics, Inc.(CODX)

$1.44—Earnings · Aug 13

Chart

Co-Diagnostics, Inc.(CODX)

NASDAQ

$1.44—Earnings · Aug 13

Chart Studio

CODX(CODX)

CODX

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-3.00

Aug 13, 2026 · Reports after close

Revenue Estimate

$132,576

FY2029E EPS$6.60

Analyst Sentiment

Wall St. Consensus

Hold

5 analysts·Limited coverage

Score

2 Buy (40%)3 Hold (60%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

240%

Hold

360%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$180.00

+12400.0%

Consensus

$180.00

+12400.0%

Bull

$180.00

+12400.0%

12-Month Target Range5 analysts

$180.00$180.00$180.00

Current $1.44Consensus

Current Price

$1.44

Upside to Consensus

$178.56

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+3011.15%

EPS—

FY2028

Rev+245.43%

EPS—

FY2029

Rev+130.09%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E
Revenue Avg	$552,400	$17M	$59M	$137M
Low	$552,400	$17M	$59M	$137M
High	$552,400	$17M	$59M	$137M
EBITDA Avg	$-312,837	$-10M	$-34M	$-77M
Low	$-312,837	$-10M	$-34M	$-77M
High	$-312,837	$-10M	$-34M	$-77M
EBIT Avg	$-317,357	$-10M	$-34M	$-78M
Low	$-317,357	$-10M	$-34M	$-78M
High	$-317,357	$-10M	$-34M	$-78M
Net Income Avg	$-16M	$-16M	$-9M	$9M
Low	$-16M	$-16M	$-9M	$9M
High	$-16M	$-16M	$-9M	$9M
EPS Avg	$-12.15	$-12.00	$-6.90	$6.60
Low	$-12.15	$-12.00	$-6.90	$6.60
High	$-12.15	$-12.00	$-6.90	$6.60
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$143,624	$149,148	$9M	$10M	$10M	$10M	$14M	$14M
Low	$143,624	$149,148	$9M	$10M	$10M	$10M	$14M	$14M
High	$143,624	$149,148	$9M	$10M	$10M	$10M	$14M	$14M
EBITDA Avg	$-81,337	$-84,466	$-5M	$-6M	$-6M	$-6M	$-8M	$-8M
Low	$-81,337	$-84,466	$-5M	$-6M	$-6M	$-6M	$-8M	$-8M
High	$-81,337	$-84,466	$-5M	$-6M	$-6M	$-6M	$-8M	$-8M
EBIT Avg	$-82,512	$-85,686	$-5M	$-6M	$-6M	$-6M	$-8M	$-8M
Low	$-82,512	$-85,686	$-5M	$-6M	$-6M	$-6M	$-8M	$-8M
High	$-82,512	$-85,686	$-5M	$-6M	$-6M	$-6M	$-8M	$-8M
Net Income Avg	$-6M	$-6M	$-2M	$-2M	$-2M	$-3M	$11M	$11M
Low	$-6M	$-6M	$-2M	$-2M	$-2M	$-3M	$11M	$11M
High	$-6M	$-6M	$-2M	$-2M	$-2M	$-3M	$11M	$11M
EPS Avg	$-2.85	$-2.70	$-0.87	$-0.88	$-0.98	$-1.22	$4.73	$4.91
Low	$-2.85	$-2.70	$-0.87	$-0.88	$-0.98	$-1.22	$4.73	$4.91
High	$-2.85	$-2.70	$-0.87	$-0.88	$-0.98	$-1.22	$4.73	$4.91
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Nov 14, 2022H.C. Wainwright

HC Wainwright & Co. Maintains Buy on Co-Diagnostics, Lowers Price Target to $6

Target:$6.00

-94.5%from $109.50

Aug 15, 2022H.C. Wainwright

HC Wainwright & Co. Maintains Buy on Co-Diagnostics, Lowers Price Target to $9

Target:$9.00

-93.3%from $134.40

May 16, 2022H.C. Wainwright

HC Wainwright & Co. Maintains Buy on Co-Diagnostics, Lowers Price Target to $12

Target:$12.00

-91.2%from $136.50

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance